Benton v. TEVA Pharmaceuticals USA, Inc. et al
| Tommy Benton |
| TEVA PHARMACEUTICALS USA INC, HETERO LABS LIMITED and HETERO USA INC. |
| VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION |
| 1:2021cv13858 |
| July 20, 2021 |
| US District Court for the District of New Jersey |
| Robert B Kugler |
| Karen M Williams |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 23, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 RETURN RECEIPT CARD re #1 Complaint (dd, ) |
| Filing 9 Clerk's Notice to Counsel. (dd, ) |
| Filing 8 Certified Copy of Transfer Order and docket received, Case transferred in from District of Alabama Middle; Case Number 3:21-cv-00453. Original file certified copy of transfer order and docket sheet received. |
| Filing 7 Received certified copy of Conditional Transfer Order entered on 7/20/2021 by the Judicial Panel on Multidistrict Litigation transferring this action to USDC for the District of New Jersey. (cwl, ) |
| Case transferred to District of New Jersey. Electronically transferred via CM/ECF transfer to Clerk. (NO pdf attached to this entry) (cwl, ) |
| Judge Robert B. Kugler and Magistrate Judge Karen M. Williams added. (dd, ) |
| Case transferred from Alabama Middle on 7/20/21 pursuant to CTO 44(dd, ) |
| For all Case Management Orders #click here (dd, ) |
| Filing 6 Return Receipt Card showing service of Summons and #1 Complaint signed by Lindsey T. for TEVA Pharmaceuticals USA, Inc. served on 7/13/2021, answer due 8/3/2021. (bes, ) |
| Filing 5 Corporate/Conflict Disclosure Statement by Tommy Benton re #2 Notice of Deficiency requiring filing of Corporate Disclosure/Conflict Statement. (Brooks, Gerald) |
| Filing 4 Summons Issued as to Hetero Labs Limited and returned to counsel for personal service under the Hague Convention by process server. (bes, ) |
| Filing 3 Summons Issued as to Hetero USA, Inc., TEVA Pharmaceuticals USA, Inc.; mailed CMRRR with a copy of the #1 Complaint. (bes, ) |
| Filing 2 Notice of Deficiency requiring filing of Corporate Disclosure/Conflict Statement sent to Tommy Benton; Corporate Disclosures due by 7/19/2021. (Attachments: #1 Standing Order and Sample Format)(bes, ) |
| Filing 1 COMPLAINT against Hetero Labs Limited, Hetero USA, Inc., TEVA Pharmaceuticals USA, Inc. ( Filing fee $ 402.00 receipt number 4602063863.), filed by Tommy Benton. (Attachments: #1 Civil Cover Sheet, #2 Receipt)(bes, ) |
| DEMAND for Trial by Jury by Tommy Benton. (No PDF attached to this entry - see doc #1 for PDF) (bes, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
